共 50 条
REVIEWING THE DYSREGULATION OF ADAMTS13 AND VWF IN SEPSIS
被引:2
|作者:
Madarati, Hasam
Singh, Kanwal
Sparring, Taylor
Andrisani, Peter
Liaw, Patricia C.
Fox-Robichaud, Alison E.
Kretz, Colin A.
机构:
[1] McMaster Univ, Dept Med, Hamilton, ON, Canada
[2] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada
来源:
关键词:
ADAMTS13;
Von Willebrand factor;
sepsis;
disseminated intravascular coagulation;
hemostasis;
coagulation;
cardiovascular disease;
thrombotic microangiopathies;
thrombotic thrombocytopenia purpura;
Von Willebrand disease;
inflammation;
neutrophil extracellular traps;
alpha-defensin;
VON-WILLEBRAND-FACTOR;
FACTOR-CLEAVING PROTEASE;
THROMBOTIC THROMBOCYTOPENIC PURPURA;
MYOCARDIAL-INFARCTION;
ISCHEMIC-STROKE;
INTRAVASCULAR COAGULATION;
INFLAMMATORY CYTOKINES;
CLINICAL-IMPLICATIONS;
ENDOTHELIAL-CELLS;
FACTOR PROPEPTIDE;
D O I:
10.1097/SHK.0000000000002291
中图分类号:
R4 [临床医学];
学科分类号:
1002 ;
100602 ;
摘要:
Sepsis is defined as a life-threatening organ dysfunction caused by excessive host response to infection, and represents the most common cause of in-hospital deaths. Sepsis accounts for 30% of all critically ill patients in the intensive care unit (ICU), and has a global mortality rate of 20%. Activation of blood coagulation during sepsis and septic shock can lead to disseminated intravascular coagulation, which is characterized by microvascular thrombosis. Von Willebrand factor (VWF) and ADAMTS13 are two important regulators of blood coagulation that may be important links between sepsis and mortality in the ICU. Herein we review our current understanding of VWF and ADAMTS13 in sepsis and other critical illnesses and discuss their contribution to disease pathophysiology, their use as markers of severe illness, and potential targets for new therapeutic development.
引用
收藏
页码:189 / 196
页数:8
相关论文